Introduction
This EUDA Precursor Assessment Report examines the evidence on 2-bromo-3′-methylpropiophenone, evaluating its licit use in the EU and the extent of its use in illicit production.
2-Bromo-3′-methylpropiophenone is a chemical precursor used for the production of 3-methylmethcathinone (3-MMC) - a synthetic cathinone stimulant drug that has been present in the drug market in the European Union (EU) since at least 2012. 3-MMC has been under EU control since 2022 and international control since 2023. The appearance of 3-MMC on the drug market coincided with the control of mephedrone in Europe and, it appears that the substance was introduced in the market as a non-controlled alternative to 4-MMC (EMCDDA, 2022). Seizures of 3-MMC in the EU included a large multi-tonne incident shipped from India.
This document was prepared at the request of the European Commission, pursuant to the Regulation (EU) 2023/1322 of the European Parliament and of the Council of 27 June 2023 on the European Union Drugs Agency (EUDA) and repealing Regulation (EC) No 1920/2006(1), particularly the Article 14 (2).
The document available here is a redacted version of the original precursor assessment report. Sections that contain detailed methodology or technical information that could be misused to enable illicit synthesis have been withheld in the interest of public safety.
Download as PDF
